Sutro Biopharma Stock Forecast - Relative Strength Index

STRO Stock  USD 1.87  0.10  5.08%   
Sutro Stock Forecast is based on your current time horizon. Although Sutro Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Sutro Biopharma's systematic risk associated with finding meaningful patterns of Sutro Biopharma fundamentals over time.
  
As of the 27th of December 2024, Asset Turnover is likely to grow to 0.46, while Inventory Turnover is likely to drop (0.67). . As of the 27th of December 2024, Common Stock Shares Outstanding is likely to drop to about 31.9 M. In addition to that, Net Loss is likely to grow to about (101.9 M).
On December 23, 2024 Sutro Biopharma had Relative Strength Index of 0.
Check Sutro Biopharma VolatilityBacktest Sutro BiopharmaTrend Details  

Sutro Biopharma Trading Date Momentum

On December 24 2024 Sutro Biopharma was traded for  1.93  at the closing time. The top price for the day was 1.93  and the lowest listed price was  1.83 . The trading volume for the day was 485.5 K. The trading history from December 24, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 3.21% . The trading price change against the current closing price is 5.35% .
Compare Sutro Biopharma to competition

Other Forecasting Options for Sutro Biopharma

For every potential investor in Sutro, whether a beginner or expert, Sutro Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sutro Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sutro. Basic forecasting techniques help filter out the noise by identifying Sutro Biopharma's price trends.

View Sutro Biopharma Related Equities

 Risk & Return  Correlation

Sutro Biopharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sutro Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sutro Biopharma's current price.

Sutro Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Sutro Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sutro Biopharma shares will generate the highest return on investment. By undertsting and applying Sutro Biopharma stock market strength indicators, traders can identify Sutro Biopharma entry and exit signals to maximize returns.

Sutro Biopharma Risk Indicators

The analysis of Sutro Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sutro Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sutro stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Sutro Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sutro Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Sutro Stock

  0.66ME 23Andme HoldingPairCorr
  0.82VALN Valneva SE ADRPairCorr

Moving against Sutro Stock

  0.81DRTS Alpha Tau MedicalPairCorr
  0.7DMAC DiaMedica TherapeuticsPairCorr
  0.7CDIOW Cardio DiagnosticsPairCorr
  0.69VCYT VeracytePairCorr
  0.67VCEL Vericel Corp OrdPairCorr
The ability to find closely correlated positions to Sutro Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sutro Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sutro Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sutro Biopharma to buy it.
The correlation of Sutro Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sutro Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sutro Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sutro Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Sutro Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sutro Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sutro Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sutro Biopharma Stock:
Check out Historical Fundamental Analysis of Sutro Biopharma to cross-verify your projections.
To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.55)
Revenue Per Share
2.253
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.18)
Return On Equity
(1.11)
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.